In-silico studies of novel triazole derivatives as inhibitor of 14α demethylase cyp51

Shrusti Rao, Varadaraj Bhat, Fajeelath Fathima, Santosh Kumar, Ruchi Verma

Research output: Contribution to journalArticlepeer-review


An antifungal agent is a drug that eliminates fungal pathogens selectively from host with negligible toxicity to the host. Antifungal agents are classified into classes like antibiotics, antimetabolite, azole, and allyl amine. In this present work, the binding mode of novel designed triazole analogues with CYP51 has been investigated by flexible molecular docking. The molecular modeling, which gives the utilization of structural information of CYP51 can enhance the discovery of novel antifungal agents. Further in silico studies were performed in order to see their drug likeness properties and possible mode of interaction with target protein residue. Molecular docking of novel molecules was done by Schrodinger software using following steps like protein preparation, ligand preparation, grid generation, molecular docking. The protein PDB selected was 5V5Z. AZ3 analogue showed the best dock score. The docking value varied from-2.578 to-8.19 for the designed ligands. All the molecules showed good ADME properties and followed Lipinski rule of five. The designed molecules can serve as a lead for future antifungal drug discovery.

Original languageEnglish
Pages (from-to)5806-5810
Number of pages5
JournalResearch Journal of Pharmacy and Technology
Issue number12
Publication statusPublished - 12-2020

All Science Journal Classification (ASJC) codes

  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  • Pharmacology (medical)


Dive into the research topics of 'In-silico studies of novel triazole derivatives as inhibitor of 14α demethylase cyp51'. Together they form a unique fingerprint.

Cite this